Replies to post #29525 on OncoSec Medical Inc (ONCSQ)

[someconcerns]

TJ, Yes, aware of the trial using both Keytruda and ONCS participation. Long-time holder of ONCS myself. I am sure both articles had the same study as their genesis. GLTAL

trading.jeff Sunday, 04/19/15 07:48:23 PM
Re: someconcerns post# 29519
Post # of 29527

$ONCS Merck has supplied its drug, Keytruda, to one of the trials that OncoSec is participating in. No doubt, Merck will be watching closely, as it will be watching the other trials in which Keytruda is being tested.

BTW, I came across this article in the WSJ re: Keytruda and melanoma:

Merck’s Keytruda Shows Improved Survival Odds in Melanoma

Immunotherapy displayed better survival rates compared with Bristol-Myers’s Yervoy

http://www.wsj.com/articles/mercks-keytruda-shows-improved-survival-odds-for-melanoma-patients-1429448169

The article is dated today but, wasn't there a trial, involving Keytruda, that was stopped early because Merck's drug showed promising results over a rival's drug? Isn't this article discussing the same?